23andMe is low on cash and its stock is worth pennies. The CEO wants another chance
By Nicole Goodkind, CNN New York (CNN) — Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Silicon Valley. Today, the firm is at risk of being delisted from the Nasdaq. But 23andMe’s CEO, Anne Wojcicki, tells CNN that Wall Street shouldn’t count her out yet. Despite the
Continue Reading